FMD K&L Inc. Celebrates 20th Anniversary

Nov 06, 2015, 08:00 ET from FMD K&L Inc.

FORT WASHINGTON, Pa., Nov. 6, 2015 /PRNewswire/ -- FMD K&L Inc. (formerly K&L Consulting Services, Inc.), a privately owned Contract Research Organization (CRO), celebrates a significant milestone of 20 years in business this week.  A special staff event is planned to commemorate this exceptional company achievement and reminisce the growth and success of the business over the years.   

Back in 1995, our co-founders, Dr. Xin Ke and Jenny Lin, held roles within large pharma and made the decision and long-term commitment to establish their own business.  They strived for the continuous challenge of growing a business from the ground up and built it on the core values of accountability, innovation, leadership, quality, and teamwork. 

"As we've built up our business to get to this milestone, we have been fortunate to retain highly talented individuals with a wealth of knowledge and experience. Because of this, I am confident that what the future holds is continued growth and success," says Dr. Xin Ke, President. 

Throughout the years, the business has continued to develop in many aspects.  From increasing staff headcounts and growth in clients we serve, various relocations and expansions, to additional service offerings; however, this hasn't affected the high quality output you come to expect when working with FMD K&L.  If anything, it has given us the challenge our co-founders desired from day one – to continue to raise the standard of excellence.

"From the first year, where the office was a room with one desk leased from Dr. Ke's friend, to just recently expanding for the fourth time in our Fort Washington, PA office and opening facilities in Armenia and Japan, you can see we're not stopping our continued growth any time soon," says Jenny Lin, VP of Operations.  "We're excited for what is yet to come in the next twenty years as we celebrate this anniversary."     

About FMD K&L Inc.

FMD K&L Inc. is a Contract Research Organization (CRO) offering data management, biostatistics, statistical programming, CDISC compliant eSubmission, drug safety, and medical writing services to the pharmaceutical, biotechnology, and medical device industries worldwide.  In addition, we provide regulatory affairs in China and South East Asia, and clinical operations in mainland China, Hong Kong, Taiwan, South Korea, and Europe.  We continuously strive to raise the standard of excellence through accuracy and efficiency.  This results in high quality output to get our client's drug or medical product approved faster and to improve the lives of patients. 

Learn more at


Catherine Ditzler 
Marketing Manager